Tudor Investment Corp’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$758K Buy
216,004
+36,510
+20% +$117K ﹤0.01% 2558
2025
Q4
$490K Buy
179,494
+57,750
+47% +$134K ﹤0.01% 2732
2025
Q3
$264K Buy
+121,744
New +$287K ﹤0.01% 3056
2025
Q2
Sell
-122,930
Closed -$409K 3674
2025
Q1
$409K Buy
+122,930
New +$634K ﹤0.01% 2394
2024
Q4
Sell
-218,927
Closed -$2.06M 3372
2024
Q3
$2.06M Sell
218,927
-80,958
-27% -$767K 0.02% 1186
2024
Q2
$2.41M Buy
299,885
+55,269
+23% +$592K 0.03% 973
2024
Q1
$3.63M Buy
244,616
+211,468
+638% +$2.46M 0.04% 762
2023
Q4
$269K Buy
+33,148
New +$173K ﹤0.01% 2072
2023
Q3
Sell
-115,277
Closed -$812K 2622
2023
Q2
$812K Buy
115,277
+57,750
+100% +$413K 0.01% 1427
2023
Q1
$351K Sell
57,527
-37,102
-39% -$256K 0.01% 1824
2022
Q4
$605K Buy
94,629
+15,849
+20% +$124K 0.01% 1455
2022
Q3
$755K Sell
78,780
-11,714
-13% -$135K 0.02% 1119
2022
Q2
$999K Buy
90,494
+60,124
+198% +$788K 0.03% 884
2022
Q1
$506K Sell
30,370
-57,162
-65% -$884K 0.01% 1274
2021
Q4
$1.67M Buy
87,532
+39,550
+82% +$871K 0.03% 730
2021
Q3
$1.18M Buy
+47,982
New +$1.13M 0.02% 1041
2021
Q2
Sell
-150,091
Closed -$4.75M 1753
2021
Q1
$4.75M Buy
+150,091
New +$6.22M 0.1% 196
2020
Q3
Sell
-31,938
Closed -$877K 1417
2020
Q2
$877K Buy
+31,938
New +$1.05M 0.04% 517
2017
Q4
Sell
-19,000
Closed -$147K 1163
2017
Q3
$147K Buy
+19,000
New +$120K 0.01% 990
2015
Q2
Sell
-18,225
Closed -$221K 1578
2015
Q1
$221K Buy
+18,225
New +$205K 0.01% 1241

Other funds holding IOVA